Berkeley Capital Partners, LLC Gsk PLC Transaction History

Berkeley Capital Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$32.47 - $48.83 $187,254 - $281,602	-5,767 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$42.0 - $48.25 $67,200 - $77,200	-1,600 Reduced 21.72%	5,767 $271,000
Q3 2019 Nov 01, 2019	SELL	$40.46 - $43.52 $51,060 - $54,922	-1,262 Reduced 14.63%	7,367 $314,000
Q2 2019 Aug 08, 2019	SELL	$39.4 - $42.7 $79,115 - $85,741	-2,008 Reduced 18.88%	8,629 $345,000
Q1 2019 Apr 30, 2019	BUY	$38.57 - $42.69 $29,081 - $32,188	754 Added 7.63%	10,637 $445,000
Q4 2018 Jan 28, 2019	BUY	$37.8 - $42.69 $373,577 - $421,905	9,883 New	9,883 $378,000
Q3 2018 Oct 30, 2018	SELL	$39.75 - $42.69 $336,285 - $361,157	-8,460 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $75,734 - $81,757	-1,912 Reduced 18.43%	8,460 $341,000
Q1 2018 Apr 27, 2018	SELL	$36.18 - $40.15 $74,458 - $82,628	-2,058 Reduced 16.56%	10,372 $405,000
Q4 2017 Feb 02, 2018	SELL	$35.34 - $41.9 $14,878 - $17,639	-421 Reduced 3.28%	12,430 $441,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $506,843 - $533,959	12,851	12,851 $522,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Berkeley Capital Partners, LLC with notifications on news.